Marston Linehan

Marston Linehan featured in “The Code” video series from STAT and Retro Report

Apr 9, 2018

“Finding the Code: The Race to Sequence the Human Genome and What it Means” is the first in a three-part series from STAT and Retro Report investigating the roots of today’s most promising genetic technologies. Marston Linehan, Ph.D., Chief of the Urologic Oncology Branch, is featured for his work on the Human Genome Project.  Read more...

Christian Hinrichs

AFP article profiles CCR’s Christian Hinrichs, a cancer survivor now leading clinical trials

Mar 27, 2018

In 2005, Christian Hinrichs, M.D., Investigator in the Experimental Transplantation and Immunology Branch, underwent surgery to remove his right eye due to a rare cancer called ocular melanoma. The operation affected his depth perception and ended his career as a cancer surgeon, but Dr. Hinrichs was determined to find a way to beat the cancer and went back to school to train as an internal medicine doctor and oncologist. In a recent article from Agence France Presse, he describes how his diagnosis now drives his quest for a cancer cure. Read the full story…

Douglas Lowy

Doug Lowy receives Science of Oncology Award and Lecture from the American Society of Clinical Oncology

Mar 15, 2018

Doug Lowy, M.D., Deputy Director of the National Cancer Institute and Chief of the Laboratory of Cellular Oncology, has received the Science of Oncology Award and Lecture from the American Society of Clinical Oncology (ASCO). The award recognizes outstanding contributions to basic or translational research in cancer and is one of ASCO’s most prestigious awards for leadership and exceptional service to transform cancer care around the world. Dr. Lowy will be honored during ASCO’s Annual Meeting in June in Chicago. Read more...

WSJ logo

Jeremy Davis featured in Wall Street Journal article on preventive surgery for stomach cancer

Mar 13, 2018

The Wall Street Journal recently reported on the growing number of individuals with a family history of stomach cancer who choose to undergo genetic testing or total stomach removal as a preventive measure. The article features Jeremy Davis, M.D., Staff Clinician in the Thoracic and Gastrointestinal Oncology Branch and Surgeon-in-Chief at the NIH Clinical Center, who notes that researchers have quite a bit to learn about a mutation in the CDH1 gene linked to an increased risk of a certain type of stomach cancer. Read the full article…


New collaborative study will explore health disparities for prostate cancer

Feb 26, 2018

A newly funded study aims to explore the relationship between chronic inflammation, ancestry and tumor biology as a cause of prostate cancer progression in men of African descent who experience a disproportionately high prostate cancer mortality rate in the U.S. and globally. As a collaborative project between NCI and external researchers, Stefan Ambs, Ph.D., M.P.H, Senior Investigator in CCR’s Laboratory of Human Carcinogenesis, will lead the study with Michael Cook, Ph.D., of NCI’s Division of Cancer Epidemiology and Genetics and Clayton Yates, Ph.D., of Tuskegee University to help address health disparities for prostate cancer. The project is funded through a Prostate Cancer Research Program Impact Award from the Department of Defense. Read more...

Scientists in lab

Three CCR accomplishments receive Excellence in Technology Transfer Awards

Feb 23, 2018

The Federal Laboratory Consortium for Technology Transfer has recognized three CCR accomplishments with Excellence in Technology Transfer Awards. This award category honors employees of FLC member laboratories and non-laboratory staff who have accomplished outstanding work in the process of transferring federally developed technology. Read more…

Three CCR accomplishments receive Excellence in Technology Transfer Awards
Dr. Michael Gottesman

Michael Gottesman receives the Dr. Nathan Davis Award for Outstanding Government Service

Feb 20, 2018

Michael Gottesman, M.D., Chief of the Laboratory of Cell Biology, has received the Dr. Nathan Davis Award for Outstanding Government Service from the American Medical Association (AMA) for his contributions to public health, medical science and the training of physician-scientists. As the AMA’s top government service award, the Dr. Nathan Davis Award recognizes elected and career officials in federal, state or municipal service whose outstanding contributions have promoted the art and science of medicine and the betterment of public health. Read more…

Lowy and Schiller

Doug Lowy and John Schiller receive the Szent-Györgyi Prize for Progress in Cancer Research

Feb 15, 2018

The National Foundation for Cancer Research (NFCR) will honor CCR’s Doug Lowy, M.D., Chief of the Laboratory of Cellular Oncology, and John Schiller, Ph.D., Deputy Chief of the Laboratory of Cellular Oncology, with the Szent-Györgyi Prize for Progress in Cancer Research during a ceremony on May 5 in Washington, D.C. The annual prize, named after NFCR’s co-founder, Albert Szent-Györgyi, M.D., Ph.D., honors scientists who have made an original discovery or breakthrough in scientific understanding that has had a lasting impact on the cancer field and saving people’s lives. In addition to the more than 150 papers co-authored by Drs. Lowy and Schiller, the duo’s research has led to great advances in understanding HPV infection and the development of three preventive HPV vaccines approved by the U.S. Food and Drug Administration. Read more…

ASCO logo

CCR scientists help develop first recommendations for managing mesothelioma

Feb 7, 2018

Anish Thomas, M.B.B.S., M.D., Investigator in the Developmental Therapeutics Branch, Markku Martti Miettinen, M.D., Ph.D., Senior Clinician in the Laboratory of Pathology, and Raffit Hassan, M.D., Co-Chief of the Thoracic and Gastrointestinal Oncology Branch, are among the contributing authors of the American Society of Clinical Oncology’s first guidelines for evidence-based recommendations on the management of mesothelioma. The guidelines were informed by 222 relevant studies. The recommendations were developed for diagnosis, staging, chemotherapy, surgical cytoreduction, radiation therapy and multimodality therapy in patients with mesothelioma. Learn more…

Kenneth Aldape, M.D.

Ken Aldape joins CCR as Chief, Laboratory of Pathology

Feb 5, 2018

Kenneth Aldape, M.D., has joined CCR as the Chief of the Laboratory of Pathology. Dr. Aldape’s research interests focus on the molecular pathogenesis and classification of brain tumors, particularly malignant gliomas and meningliomas. His passion is to apply new molecular technologies to classify tumors from a biological perspective. Learn more...